[Kininogenesis indices in lupus erythematosus]. 1981

V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova

UI MeSH Term Description Entries
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008179 Lupus Erythematosus, Discoid A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur. Lupus Erythematosus, Chronic Cutaneous,Lupus Erythematosus, Cutaneous, Chronic,Discoid Lupus Erythematosus
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010184 Pancreatic Extracts Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency. Pancreatic Extract,Pancreatic Tissue Extract,Pancreatic Tissue Extracts,Extract, Pancreatic,Extract, Pancreatic Tissue,Extracts, Pancreatic,Extracts, Pancreatic Tissue,Tissue Extract, Pancreatic,Tissue Extracts, Pancreatic
D011205 Povidone A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Polvidone,Polyvidon,Polyvinylpyrrolidone,Arufil,Bolinan,Bolinan 40,Crospovidone,Dulcilarmes,Duratears Free,Enterodes,Enterodez,Hypotears,Kollidon,Lacophtal,Lacri-Stulln,Lagrifilm,Liquifilm Lagrimas,Nutrivisc,Oculotect,PVP 40,Periston,Plasdone,Polyplasdone XL,Povidone, Unspecified,Protagens,Protagent,Unifluid,Vidirakt S mit PVP,Vidisic PVP Ophtiole,Wet-Comod,Dulcilarme,Enterode,Hypotear,Polyvidons,Protagen,Unspecified Povidone
D011288 Prekallikrein A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. Fletcher Factor,Plasma Prokallikrein,Kallikreinogen,Plasma Prokallikrein A,Factor, Fletcher,Prokallikrein A, Plasma,Prokallikrein, Plasma
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
May 1983, Biulleten' eksperimental'noi biologii i meditsiny,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
March 1965, Vestnik dermatologii i venerologii,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
February 1986, Kardiologiia,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
February 2016, Arthritis care & research,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
April 1978, Vestnik dermatologii i venerologii,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
April 1979, Vestnik dermatologii i venerologii,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
January 2024, Reumatologia,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
January 1982, Terapevticheskii arkhiv,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
September 1965, Sovetskaia meditsina,
V A Kuznetsov, and N V Beliakov, and E P Sbitneva, and T D Bol'shakova
January 1999, Minerva medica,
Copied contents to your clipboard!